18 Comments
Jul 25, 2020Liked by Benjamin Jolley

Its a very nice article, explaining how the new orders affect pharmacy profession! I really enjoyed reading it!

Expand full comment

That is a very good explanation. Unfortunately, the PBMs will begin pressuring Congress as they line the pockets through their lobbyists and paint a very unrealistic picture of the "benefits" they create for medicare. Education such as you provide here will hopefully gain traction and we as pharmacists can gain traction in this tainted world of politics and deception.

Expand full comment

If you keep writing like this and we all can actually get people (patients, Congress, state legislatures, the president) to read it, maybe the whole system will change for the better

Expand full comment

Adam Fein is not friend of pharmacies or 340B program. He is bought and paid for my PhRMA and PBMs. Challenge him on his facts about 340B and he will block you on Twitter. Fact is the discounted price for EpiPens, insulin and almost all other drugs are passed on to the patient already. I’ve worked in 340B for 20 years and that has been the primary model y hospitals and FQHC’s. Our uninsured patients have paid no more than $20 for EpiPens and most insulin’s for years.

Expand full comment

Good job Ben. You should post this in a word document so we can share this. At least maybe email it to me. Thanks

Expand full comment

The minorest of quibbles here - but Stelara isn't a 20,000/month drug. It's at worst 20,000/2 months for ulcerative colitis, or 10,000/3 months for a sub-220 lb psoriasis patient. Doesn't affect the point at all, but just the numbers being used!

Expand full comment

Your description of kickbacks was great. Wish I could share this with my customers & friends

Expand full comment